{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:54:58Z","timestamp":1771062898512,"version":"3.50.1"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFA0502301"],"award-info":[{"award-number":["2016YFA0502301"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["21ZR1475600"],"award-info":[{"award-number":["21ZR1475600"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U19A2067"],"award-info":[{"award-number":["U19A2067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Target prediction and virtual screening are two powerful tools of computer-aided drug design. Target identification is of great significance for hit discovery, lead optimization, drug repurposing and elucidation of the mechanism. Virtual screening can improve the hit rate of drug screening to shorten the cycle of drug discovery and development. Therefore, target prediction and virtual screening are of great importance for developing highly effective drugs against COVID-19. Here we present D3AI-CoV, a platform for target prediction and virtual screening for the discovery of anti-COVID-19 drugs. The platform is composed of three newly developed deep learning-based models i.e., MultiDTI, MPNNs-CNN and MPNNs-CNN-R models. To compare the predictive performance of D3AI-CoV with other methods, an external test set, named Test-78, was prepared, which consists of 39 newly published independent active compounds and 39 inactive compounds from DrugBank. For target prediction, the areas under the receiver operating characteristic curves (AUCs) of MultiDTI and MPNNs-CNN models are 0.93 and 0.91, respectively, whereas the AUCs of the other reported approaches range from 0.51 to 0.74. For virtual screening, the hit rate of D3AI-CoV is also better than other methods. D3AI-CoV is available for free as a web application at http:\/\/www.d3pharma.com\/D3Targets-2019-nCoV\/D3AI-CoV\/index.php, which can serve as a rapid online tool for predicting potential targets for active compounds and for identifying active molecules against a specific target protein for COVID-19 treatment.<\/jats:p>","DOI":"10.1093\/bib\/bbac147","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T11:16:25Z","timestamp":1649934985000},"source":"Crossref","is-referenced-by-count":21,"title":["D3AI-CoV: a deep learning platform for predicting drug targets and for virtual screening against COVID-19"],"prefix":"10.1093","volume":"23","author":[{"given":"Yanqing","family":"Yang","sequence":"first","affiliation":[{"name":"CAS Key Laboratory of Receptor Research, Stake Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai, 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deshan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Computer Science, Hunan University , Changsha, 410082, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinben","family":"Zhang","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Receptor Research, Stake Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai, 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"Shi","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Receptor Research, Stake Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai, 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Han","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Nanjing University of Chinese Medicine , Nanjing, 210046, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Zhou","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Receptor Research, Stake Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai, 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyun","family":"Wu","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Receptor Research, Stake Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai, 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minfei","family":"Ma","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Receptor Research, Stake Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai, 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jintian","family":"Li","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Receptor Research, Stake Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai, 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoliang","family":"Peng","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Receptor Research, Stake Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai, 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3063-8473","authenticated-orcid":false,"given":"Zhijian","family":"Xu","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Receptor Research, Stake Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai, 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiliang","family":"Zhu","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Receptor Research, Stake Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai, 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"key":"2022072511292129200_ref1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"2022072511292129200_ref2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"2022072511292129200_ref3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"2022072511292129200_ref4","author":"Weekly epidemiological update on COVID-19 - 28 December 2021"},{"key":"2022072511292129200_ref5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"2022072511292129200_ref6","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/j.cell.2021.04.045","article-title":"High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies","volume":"184","author":"Garrett","year":"2021","journal-title":"Cell"},{"key":"2022072511292129200_ref7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.apsb.2020.04.006","article-title":"D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19","volume":"10","author":"Shi","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"2022072511292129200_ref8","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1021\/acs.jcim.9b00332","article-title":"D3Pockets: a method and web server for systematic analysis of protein pocket dynamics","volume":"59","author":"Chen","year":"2019","journal-title":"J Chem Inf Model"},{"key":"2022072511292129200_ref9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/bib\/bbaa422","article-title":"Ligand-based approach for predicting drug targets and for virtual screening against COVID-19","volume":"22","author":"Yang","year":"2021","journal-title":"Brief Bioinform"},{"key":"2022072511292129200_ref10","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1093\/bioinformatics\/btaa645","article-title":"COVID-19 Docking server: a meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19","volume":"36","author":"Kong","year":"2020","journal-title":"Bioinformatics"},{"key":"2022072511292129200_ref11","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1021\/acs.jcim.0c00821","article-title":"Systemic in silico screening in drug discovery for coronavirus disease (COVID-19) with an online interactive web server","volume":"60","author":"Xu","year":"2020","journal-title":"J Chem Inf Model"},{"key":"2022072511292129200_ref12","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1038\/s41598-021-84700-0","article-title":"Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants","volume":"11","author":"Guedes","year":"2021","journal-title":"Sci Rep"},{"key":"2022072511292129200_ref13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bib\/bbaa155","article-title":"Virus-CKB: an integrated bioinformatics platform and analysis resource for COVID-19 research","volume":"22","author":"Feng","year":"2020","journal-title":"Brief Bioinform"},{"key":"2022072511292129200_ref14","article-title":"MolAICal: a soft tool for 3D drug design of protein targets by artificial intelligence and classical algorithm","volume":"22","author":"Bai","year":"2020","journal-title":"Brief Bioinform"},{"key":"2022072511292129200_ref15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s42256-021-00335-w","article-title":"A machine learning platform to estimate anti-SARS-CoV-2 activities","volume":"3","author":"Kc","year":"2021","journal-title":"Nat Mach Intel"},{"key":"2022072511292129200_ref16","author":"Artificial intelligence for drug discovery"},{"key":"2022072511292129200_ref17","author":"Ibm Watson"},{"key":"2022072511292129200_ref18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nbt0717-604","article-title":"AI-powered drug discovery captures pharma interest","volume":"35","author":"Smalley","year":"2017","journal-title":"Nat Biotechnol"},{"key":"2022072511292129200_ref19","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","article-title":"A deep learning approach to antibiotic discovery","volume":"180","author":"Stokes","year":"2020","journal-title":"Cell"},{"key":"2022072511292129200_ref20","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","article-title":"Deep learning enables rapid identification of potent DDR1 kinase inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat Biotechnol"},{"key":"2022072511292129200_ref21","article-title":"Rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 1.3 billion compounds Mol","volume":"39","author":"Ton","year":"2020","journal-title":"Inform"},{"key":"2022072511292129200_ref22","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab211","article-title":"A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2","volume":"22","author":"Wang","year":"2021","journal-title":"Brief Bioinform"},{"key":"2022072511292129200_ref23","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.csbj.2020.03.025","article-title":"Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model","volume":"18","author":"Beck","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"key":"2022072511292129200_ref24","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104359","article-title":"Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning","volume":"133","author":"Kadioglu","year":"2021","journal-title":"Comput Biol Med"},{"key":"2022072511292129200_ref25","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"The Lancet"},{"key":"2022072511292129200_ref26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.joim.2020.02.005","article-title":"In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus","volume":"18","author":"Zhang","year":"2020","journal-title":"J Integr Med"},{"key":"2022072511292129200_ref27","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btab473","article-title":"MultiDTI: drug-target interaction prediction based on multi-modal representation learning to bridge the gap between new chemical entities and known heterogeneous network","volume":"37","author":"Zhou","year":"2021","journal-title":"Bioinformatics"},{"key":"2022072511292129200_ref28","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.3390\/ijms20143389","article-title":"Chemi-net: a molecular graph convolutional network for accurate drug property prediction","volume":"20","author":"Liu","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2022072511292129200_ref29","first-page":"1263","article-title":"Neural message passing for quantum chemistry","volume":"70","author":"Gilmer","year":"2017","journal-title":"Int Conf Mach Learn"},{"key":"2022072511292129200_ref30","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1109\/5.726791","article-title":"Gradient-based learning applied to document recognition","volume":"86","author":"LeCun","year":"1998","journal-title":"Proc IEEE"},{"key":"2022072511292129200_ref31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J Chem"},{"key":"2022072511292129200_ref32","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","article-title":"UniProt: the universal protein knowledgebase in 2021","volume":"49","author":"UniProt","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2022072511292129200_ref33","volume-title":"RDKit: open-source Cheminformatics Sofware","author":"Landrum"},{"key":"2022072511292129200_ref34","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2022072511292129200_ref35","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41586-021-03431-4","article-title":"Clofazimine broadly inhibits coronaviruses including SARS-CoV-2","volume":"593","author":"Yuan","year":"2021","journal-title":"Nature"},{"key":"2022072511292129200_ref36","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/s41467-021-22580-8","article-title":"Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model","volume":"12","author":"Rosenke","year":"2021","journal-title":"Nat Commun"},{"key":"2022072511292129200_ref37","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41422-020-00398-1","article-title":"25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor","volume":"30","author":"Zu","year":"2020","journal-title":"Cell Res"},{"key":"2022072511292129200_ref38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021579118","article-title":"Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection","volume":"118","author":"Jan","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022072511292129200_ref39","doi-asserted-by":"crossref","first-page":"e02479","DOI":"10.1128\/AAC.02479-20","article-title":"AT-527, a double prodrug of a guanosine nucleotide analog, is a potent inhibitor of SARS-CoV-2 in vitro and a promising oral antiviral for treatment of COVID-19","volume":"65","author":"Good","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072511292129200_ref40","article-title":"Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro","volume":"185","author":"Svenningsen","year":"2020","journal-title":"Antiviral Res"},{"key":"2022072511292129200_ref41","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba7910","article-title":"Viruses harness Yxx\u00d8 motif to interact with host AP2M1 for replication: a vulnerable broad-spectrum antiviral target","volume":"6","author":"Yuan","year":"2020","journal-title":"Sci Adv"},{"key":"2022072511292129200_ref42","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107618","article-title":"Glycyrrhizin: an alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?","volume":"214","author":"Bailly","year":"2020","journal-title":"Pharmacol Ther"},{"key":"2022072511292129200_ref43","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0140-6736(03)13615-X","article-title":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus","volume":"361","author":"Cinatl","year":"2003","journal-title":"Lancet"},{"key":"2022072511292129200_ref44","first-page":"4538","article-title":"Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease","volume":"10","author":"Wang","year":"2020","journal-title":"Am J Cancer Res"},{"key":"2022072511292129200_ref45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41586-021-03491-6","article-title":"Drugs that inhibit TMEM16 proteins block SARS-CoV-2 Spike-induced syncytia","volume":"594","author":"Braga","year":"2021","journal-title":"Nature"},{"key":"2022072511292129200_ref46","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10637-011-9685-6","article-title":"Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest","volume":"30","author":"Kim","year":"2012","journal-title":"Invest New Drugs"},{"key":"2022072511292129200_ref47","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molcel.2020.08.006","article-title":"Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication","volume":"80","author":"Klann","year":"2020","journal-title":"Mol Cell"},{"key":"2022072511292129200_ref48","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.abf4058","article-title":"Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A","volume":"371","author":"White","year":"2021","journal-title":"Science"},{"key":"2022072511292129200_ref49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41564-020-00835-2","article-title":"Therapeutically administered ribonucleoside analogue MK-4482\/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets","volume":"6","author":"Cox","year":"2021","journal-title":"Nat Microbiol"},{"key":"2022072511292129200_ref50","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.abf1611","article-title":"SARS-CoV-2 M(pro) inhibitors with antiviral activity in a transgenic mouse model","volume":"371","author":"Qiao","year":"2021","journal-title":"Science"},{"key":"2022072511292129200_ref51","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147973","article-title":"Structure-based phylogeny identifies Avoralstat as a TMPRSS2 inhibitor that prevents SARS-CoV-2 infection in mice","volume":"131","author":"Sun","year":"2021","journal-title":"J Clin Invest"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/23\/3\/bbac147\/45055031\/bbac147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/23\/3\/bbac147\/45055031\/bbac147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T11:30:25Z","timestamp":1658748625000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbac147\/6571526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5,13]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbac147","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,25]]},"published":{"date-parts":[[2022,4,21]]},"article-number":"bbac147"}}